GLP-1 Therapies Lower HFpEF Hospitalizations

Summary of pooled data showing semaglutide and tirzepatide reduce heart-failure hospitalizations and all-cause mortality in patients with obesity- and diabetes-associated HFpEF.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app